Research & Development
Innovation is our answer to medical challenges. We continuously invest in medical research and promising technologies to develop and provide new drugs and diagnostics to the patient.
One innovative technology is known as the phenomenon of RNA interference also described as Post Transcriptional Gene Silencing. It was first observed in plants and awarded the Nobel prize in 1998. Shortly after the discovery of RNAi, researchers all over the world heralded RNAi as a revolution in biology and rapidly recognized the usefulness of synthetic siRNAs as a research tool, e.g. for elucidating biological pathways. In particular in the pharmaceutical industry, RNAi is widely used for the identification and validation of new therapeutic targets.
Attached media for this topic
| Title | Type | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Documents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Background Information RNAi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Progress Nature 6/2007 (reprint) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Presentation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RNAi Overview Roche Kulmbach | PDF (2.6 MB) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||